The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Lenz Robert A. since 2024.
This trader's CIK number is 1992908.
At the time of last reporting, Lenz Robert A. was the Head of R&D of Neumora Therapeutics, Inc.. (stock ticker symbol NMRA).
Also see all insider trading activities at Neumora Therapeutics, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2025 | NMRA | 0 | $0 | 5,614 | $9,380 | 0 | $0 |
| 2024 | NMRA | 0 | $0 | 88,235 | $1,077,592 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-02-18 | NMRA | Sale | 5,614 | 1.67 | 9,380 |
| 2024-10-10 | NMRA | Sale | 8,260 | 15.09 | 124,602 |
| 2024-10-09 | NMRA | Sale | 5,563 | 15.01 | 83,506 |
| 2024-09-18 | NMRA | Sale | 10,676 | 12.09 | 129,094 |
| 2024-09-17 | NMRA | Sale | 30,788 | 11.81 | 363,729 |
| 2024-09-12 | NMRA | Sale | 32,948 | 11.43 | 376,661 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Lenz Robert A. (Head of R&D of Neumora Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.